Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced Magnetics GastroMark MRI contrast agent direct price is $50-75 per dose.

This article was originally published in The Gray Sheet

Executive Summary

ADVANCED MAGNETICS GASTROMARK TO BE AVAILABLE BY MARCH 1997 following FDA's Dec. 6 approval of the agent "for oral use with magnetic resonance imaging to enhance the delineation of the bowel to distinguish it from organs and tissues that are adjacent to the upper regions of the gastrointestinal tract." Mallinckrodt will market and distribute GastroMark (ferumoxsil oral suspension); the approval triggers a $500,000 milestone payment to Advanced Magnetics.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel